Phase II trial of imatinib mesylate in patients with PDGFRA/B-negative hypereosinophilic syndrome.
Kim DH, Kim S, Park S, Byun JM, Hong J, Shin DY, Kim I, Bang SM, Lee JO, Lee JY, Kim SA, Kim KH, Chung YJ, Jung SH, Koh Y, Yoon SS.
Kim DH, et al. Among authors: chung yj.
Br J Haematol. 2024 Oct 10. doi: 10.1111/bjh.19828. Online ahead of print.
Br J Haematol. 2024.
PMID: 39389908